Skip to main content
. 2021 Apr 2;7(4):e06648. doi: 10.1016/j.heliyon.2021.e06648

Table 1.

Effect of total extract and supernatant on lipid profil.

NC HC TE 500 Sup 100 Met 100
Serum
TG (g.L−1) 0.36 ± 0.04 1.08 ± 0.05#### 0.73 ± 0.04 0.41 ± 0.07∗∗∗∗ 0.83 ± 0.11
Chol-T (g.L−1) 1.29 ± 0.06 1.59 ± 0.13 1.55 ± 0.18 1.17 ± 0.07 1.18 ± 0.09
HDL-C (g.L−1) 1.01 ± 0.05 0.92 ± 0.06 1.26 ± 0.10 1.10 ± 0.09 0.93 ± 0.03
LDL-C (g.L−1) 0.28 ± 0.04 0.69 ± 0.11# 0.36 ± 0.14 0.14 ± 0.04∗∗ 0.23 ± 0.08
VLDL-C (mg.dL−1)
7.2 ± 0.9
21.6 ± 1.1####
14.8 ± 1.0
8.2 ± 1.6∗∗∗∗
16.6 ± 2.2
Liver
TG (g.L−1) 0.43 ± 0.04 1.15 ± 0.11#### 0.49 ± 0.03∗∗∗∗ 0.30 ± 0.03∗∗∗∗ 0.67 ± 0.05∗∗∗
VLDL-C (mg.dL−1) 9.26 ± 0.88 23.02 ± 2.37#### 11.13 ± 1.28∗∗∗∗ 5.26 ± 0.55∗∗∗∗ 13.36 ± 1.05∗∗∗

The NC and HC groups received distilled water and the groups (TE 500, Sup 100 and Met 100) were treated respectively with total extract (500 mg.Kg−1), supernatant (100 mg.Kg−1) and metformin (100 mg.Kg−1) for 4 days. The results are treated with Anova one way and represent the mean ± ESM. ∗p < 0.05 ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001: Compared to hyperlipidemic control (HC); ####p < 0.0001; #p < 0.05: Compared to normal control (NC).